SmallCapReview: Small Caps To Watch Thursday - FNSR, MJNA, PRGX
(M2 PressWIRE Via Acquire Media NewsEdge) Finisar Corporation (Nasdaq: FNSR) $13.35. Announced Wednesday after market close financial results for its second fiscal quarter ended October 28, 2012.Revenues increased to $232.0 million, an increase of $11.5 million, or 5.2%, from $220.5 million in the preceding quarter, primarily driven by growth in revenues from tunable XFP transceivers and wavelength selective switches, including ROADM line cards.
GAAP operating income (loss) increased $5.3 million to $54,000, or 0.0 % of revenues, compared to an operating loss of $(5.2) million, or (2.4)% of revenues, in the preceding quarter. Non-GAAP EBITDA increased $3.9 million to $28.7 million, or 12.4% of revenues, compared to $24.9 million, or 11.3% of revenues, in the preceding quarter.
What They Do: Finisar Corporation ( NASDAQ : FNSR ) is a global technology leader for fiber optic subsystems and componentsthat enable high-speed voice, video and data communications for telecommunications, networking, storage, wireless, and cable TV applications.
SmallCapVoice.com announced today that a new audio interview with Medical Marijuana Inc. (MJNA) $0.10, a leading hemp industry innovator, is now available. The interview can be heard at http://smallcapvoice.com/blog/12-4-12-smallcapvoice-interview-with-medical-marijuana-inc-mjna.Medical Marijuana, Inc. (MJNA), a leading cannabis and hemp industry innovator, recently announced its third quarter earnings.
The company earned net income of approximately $1.19 million on gross revenues of $3.00 million for the quarter ended Sept 30, 2012. This represents a gross revenue increase of 1500 plus percent quarter-over-quarter when compared to revenue of $198,813 for the quarter ended Sept 30, 2011.
The interview also goes over the exciting growth in the entire medical marijuana market, the new markets for the Company, the goals for MJNA in 2013, an update on the up listing efforts by the company and much more.
What They Do: MJNA's mission is to be the premier cannabis and hemp industry innovators, leveraging its team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.
RGX Global (Nasdaq: PRGX) $6.39. Today announced that it has priced a public offering of 6,249,234 shares of its common stock, consisting of 2,500,000 shares to be sold by the Company and 3,749,234 shares to be sold by certain selling shareholders at a price to the public of $6.39 per share.
William Blair & Company, L.L.C. and Robert W. Baird & Co. Incorporated are serving as joint book-running managers of the public offering, and Barrington Research Associates, Inc. and B. Riley & Co., LLC are serving as co-managers of the public offering. The Company granted the underwriters a 30-day option to purchase up to an additional 937,385 shares at the public offering price, less the underwriting discount, to cover over-allotments, if any. Subject to customary conditions, the offering is expected to close on or about December 11, 2012.
The net proceeds to the Company of the public offering, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $14.6 million (or approximately $20.2 million if the underwriters exercise their over-allotment in full). The Company intends to use the net proceeds from the public offering for working capital and general corporate purposes, including potential acquisitions. The Company will not receive any proceeds from the sale of shares by the selling shareholders.
What They Do: PRGX Global, Inc. is the world's leading provider of recovery audit services. With over 1,600 employees, the Company operates and serves clients in more than 30 countries and provides its services to over 75% of the top 30 global retailers.
Copyright SmallCapReview. SmallCapReview.com has been a leading site for information on Small Cap Stocks, Penny Stocks and Microcaps since 1999. Visit http://SmallCapReview.com to sign up for our FREE newsletter. SmallCapReview has been compensated six thousand dollars by a third party SCV for its efforts with regards to Medical Marijuana.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com)).
(c) 2012 M2 COMMUNICATIONS
[ Back To Financial Technology's Homepage ]